SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Aronex Pharma (ARNX)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Robert Floyd who wrote (196)12/10/1998 12:58:00 PM
From: Dexter Enders  Read Replies (1) of 320
 
MAA status:
I sent two e-mails to get this response....

----------------------------------------------------------------
From: Connie Stout <cstout@aronex-pharm.com>Add to Address Book
To:'Dexter Enders' <enders@yahoo.com>
Subject: RE: Status of Nyotran
Date: Thu, 10 Dec 1998 10:16:09 -0600

We have amended our agreement with Ferrer to enable Abbott to pursue an optimal registration and commercialization strategy in all international markets. The discussion regarding the MAA is part of this strategy.

I hope the above answers your question. Thank you.

Connie Stout
-------------------------------------------------------------------

It still doesn't really answer the question. I don't think she can give any real information on the status....
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News